Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. [electronic resource]
- Molecular cancer therapeutics Jul 2002
- 695-706 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
1535-7163
Antibodies, Monoclonal--pharmacology Antibodies, Monoclonal, Humanized Antineoplastic Agents--pharmacology Blotting, Western Breast Neoplasms--drug therapy Cell Cycle Cell Division--drug effects Cell Separation Chromones--pharmacology Cyclin D1--metabolism Dose-Response Relationship, Drug Enzyme Inhibitors--pharmacology Flavonoids--pharmacology Flow Cytometry Humans Mitogen-Activated Protein Kinases--metabolism Morpholines--pharmacology Piperidines--pharmacology Protein Serine-Threonine Kinases Proto-Oncogene Proteins--metabolism Proto-Oncogene Proteins c-akt S Phase Signal Transduction Time Factors Transfection Trastuzumab Tumor Cells, Cultured